{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:30:11Z","timestamp":1764174611885},"reference-count":37,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9868","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T09:39:20Z","timestamp":1545644360000},"source":"Crossref","is-referenced-by-count":1,"title":["Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients"],"prefix":"10.3892","author":[{"given":"Xue","family":"Yang","sequence":"first","affiliation":[{"name":"Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiju","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhou","family":"Mou","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibing","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"key":"key20200714085446_b1-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20200714085446_b2-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.24710","article-title":"Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992\u20132008","volume":"55","author":"Altekruse","year":"2012","journal-title":"Hepatology"},{"key":"key20200714085446_b3-ol-0-0-9868","unstructured":"US National Library of MedicineClinicalTrials.govhttp:\/\/www.Clinicaltrials.gov\/ct2\/Show\/NCT025627552015"},{"key":"key20200714085446_b4-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1073\/pnas.261452898","article-title":"The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction","volume":"98","author":"Cohen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714085446_b5-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0092-8674(02)00912-1","article-title":"Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape","volume":"110","author":"Walters","year":"2002","journal-title":"Cell"},{"key":"key20200714085446_b6-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.pcan.4500661","article-title":"Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: Implications for gene therapy strategies","volume":"6","author":"Pandha","year":"2003","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20200714085446_b7-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/156800907780058826","article-title":"Oncolytic virus therapy-foreword","volume":"7","author":"Kasuya","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"key20200714085446_b8-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.3748\/wjg.v13.i47.6365","article-title":"Analysis of the expression of coxsackievirus and adenovirus receptor in five colon cancer cell lines","volume":"13","author":"Abdolazimi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20200714085446_b9-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/sj.bjc.6604876","article-title":"Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression","volume":"100","author":"Anders","year":"2009","journal-title":"Br J Cancer"},{"key":"key20200714085446_b10-ol-0-0-9868","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/1078-0432.351.11.1","article-title":"A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses","volume":"11","author":"Wang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20200714085446_b11-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/ijc.22852","article-title":"Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells","volume":"121","author":"Yamashita","year":"2007","journal-title":"Int J Cancer"},{"key":"key20200714085446_b12-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cgt.2012.80","article-title":"Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection","volume":"20","author":"Wunder","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"key20200714085446_b13-ol-0-0-9868","first-page":"1057","article-title":"Coxsackie adenovirus receptor expression in carcinomas of the head and neck","volume":"32","author":"Wunder","year":"2012","journal-title":"Anticancer Res"},{"key":"key20200714085446_b14-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.urology.2005.02.033","article-title":"Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer","volume":"66","author":"Matsumoto","year":"2005","journal-title":"Urology"},{"key":"key20200714085446_b15-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00109-011-0742-6","article-title":"Novel splice variant CAR 4\/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis","volume":"89","author":"Dietel","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"key20200714085446_b16-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1477-7819-6-59","article-title":"Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: Possible clinical implications","volume":"6","author":"Giaginis","year":"2008","journal-title":"World J Surg Oncol"},{"key":"key20200714085446_b17-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10238-005-0076-1","article-title":"The Coxsackie-adenovirus receptor has elevated expression in human breast cancer","volume":"5","author":"Martin","year":"2005","journal-title":"Clin Exp Med"},{"key":"key20200714085446_b18-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/viro.2000.0324","article-title":"The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus","volume":"271","author":"Martino","year":"2000","journal-title":"Virology"},{"key":"key20200714085446_b19-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-005-9055-3","article-title":"Cell type- and region-dependent coxsackie adenovirus receptor expression in the central nervous system","volume":"78","author":"Persson","year":"2006","journal-title":"J Neurooncol"},{"key":"key20200714085446_b20-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/ijc.22580","article-title":"Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer","volume":"120","author":"Reimer","year":"2007","journal-title":"Int J Cancer"},{"key":"key20200714085446_b21-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10735-006-9055-4","article-title":"Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers","volume":"37","author":"Wang","year":"2006","journal-title":"J Mol Histol"},{"key":"key20200714085446_b22-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-016-0313-3","article-title":"CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma","volume":"35","author":"Jiang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"key20200714085446_b23-ol-0-0-9868","first-page":"5737","article-title":"Molecular targeted therapies in hepatocellular carcinoma: Past, present and future","volume":"35","author":"Stotz","year":"2015","journal-title":"Anticancer Res"},{"key":"key20200714085446_b24-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"e0146456","DOI":"10.1371\/journal.pone.0146456","article-title":"The efficacy of continued sorafenib treatment after radiologic confirmation of progressive disease in patients with advanced hepatocellular carcinoma","volume":"11","author":"Wada","year":"2016","journal-title":"PLoS One"},{"key":"key20200714085446_b25-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1574884710666151020100059","article-title":"Advances in the pharmacologic treatment of hepatocellular carcinoma","volume":"10","author":"Bhayani","year":"2015","journal-title":"Curr Clin Pharmacol"},{"key":"key20200714085446_b26-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/bjc.2011.116","article-title":"Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer","volume":"104","author":"Stecker","year":"2011","journal-title":"Br J Cancer"},{"key":"key20200714085446_b27-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1099\/vir.0.000098","article-title":"Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma","volume":"96","author":"Jebar","year":"2015","journal-title":"J Gen Virol"},{"key":"key20200714085446_b28-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3748\/wjg.v22.i1.326","article-title":"Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20200714085446_b29-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1476-4598-12-103","article-title":"Oncolytic viruses as therapeutic cancer vaccines","volume":"12","author":"Bartlett","year":"2013","journal-title":"Mol Cancer"},{"key":"key20200714085446_b30-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.18632\/oncotarget.5116","article-title":"Going viral: A review of replication-selective oncolytic adenoviruses","volume":"6","author":"Larson","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714085446_b31-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: Focus on translational and clinical data","volume":"8","author":"Pesonen","year":"2011","journal-title":"Mol Pharm"},{"key":"key20200714085446_b32-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"key20200714085446_b33-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr Gene Ther"},{"key":"key20200714085446_b34-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/jca.5046","article-title":"Dendritic cells in the cancer microenvironment","volume":"4","author":"Ma","year":"2013","journal-title":"J Cancer"},{"key":"key20200714085446_b35-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.virol.2015.10.019","article-title":"Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo","volume":"487","author":"Gomez-Gutierrez","year":"2016","journal-title":"Virology"},{"key":"key20200714085446_b36-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/sj.cgt.7700902","article-title":"Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region","volume":"13","author":"Saito","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"key20200714085446_b37-ol-0-0-9868","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/abbs\/gms031","article-title":"Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy","volume":"44","author":"Cai","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T01:07:07Z","timestamp":1662685627000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,24]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9868","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,24]]}}}